203 related articles for article (PubMed ID: 12200048)
21. The effect of the interferon-gamma-inducible processing machinery on the generation of a naturally tumor-associated human cytotoxic T lymphocyte epitope within a wild-type and mutant p53 sequence context.
Kuckelkorn U; Ferreira EA; Drung I; Liewer U; Kloetzel PM; Theobald M
Eur J Immunol; 2002 May; 32(5):1368-75. PubMed ID: 11981824
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
[TBL] [Abstract][Full Text] [Related]
23. The N-terminal flanking region of the TRP2360-368 melanoma antigen determines proteasome activator PA28 requirement for epitope liberation.
Textoris-Taube K; Henklein P; Pollmann S; Bergann T; Weisshoff H; Seifert U; Drung I; Mügge C; Sijts A; Kloetzel PM; Kuckelkorn U
J Biol Chem; 2007 Apr; 282(17):12749-54. PubMed ID: 17308306
[TBL] [Abstract][Full Text] [Related]
24. The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.
Kloetzel PM; Soza A; Stohwasser R
Biol Chem; 1999 Mar; 380(3):293-7. PubMed ID: 10223331
[TBL] [Abstract][Full Text] [Related]
25. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.
Sijts AJ; Standera S; Toes RE; Ruppert T; Beekman NJ; van Veelen PA; Ossendorp FA; Melief CJ; Kloetzel PM
J Immunol; 2000 May; 164(9):4500-6. PubMed ID: 10779750
[TBL] [Abstract][Full Text] [Related]
26. IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
Sewell AK; Price DA; Teisserenc H; Booth BL; Gileadi U; Flavin FM; Trowsdale J; Phillips RE; Cerundolo V
J Immunol; 1999 Jun; 162(12):7075-9. PubMed ID: 10358150
[TBL] [Abstract][Full Text] [Related]
27. Antigen presentation by MHC class I and its regulation by interferon gamma.
Früh K; Yang Y
Curr Opin Immunol; 1999 Feb; 11(1):76-81. PubMed ID: 10047537
[TBL] [Abstract][Full Text] [Related]
28. The role of the proteasome in the generation of MHC class I ligands and immune responses.
Sijts EJ; Kloetzel PM
Cell Mol Life Sci; 2011 May; 68(9):1491-502. PubMed ID: 21387144
[TBL] [Abstract][Full Text] [Related]
29. LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes.
Sibille C; Gould KG; Willard-Gallo K; Thomson S; Rivett AJ; Powis S; Butcher GW; De Baetselier P
Curr Biol; 1995 Aug; 5(8):923-30. PubMed ID: 7583150
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
[TBL] [Abstract][Full Text] [Related]
31. The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35 -specific T-cell recognition.
Keller M; Ebstein F; Bürger E; Textoris-Taube K; Gorny X; Urban S; Zhao F; Dannenberg T; Sucker A; Keller C; Saveanu L; Krüger E; Rothkötter HJ; Dahlmann B; Henklein P; Voigt A; Kuckelkorn U; Paschen A; Kloetzel PM; Seifert U
Eur J Immunol; 2015 Dec; 45(12):3257-68. PubMed ID: 26399368
[TBL] [Abstract][Full Text] [Related]
32. PI31 is a modulator of proteasome formation and antigen processing.
Zaiss DM; Standera S; Kloetzel PM; Sijts AJ
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14344-9. PubMed ID: 12374861
[TBL] [Abstract][Full Text] [Related]
33. Molecular properties of the proteasome activator PA28 family proteins and gamma-interferon regulation.
Tanahashi N; Yokota K; Ahn JY; Chung CH; Fujiwara T; Takahashi E; DeMartino GN; Slaughter CA; Toyonaga T; Yamamura K; Shimbara N; Tanaka K
Genes Cells; 1997 Mar; 2(3):195-211. PubMed ID: 9189757
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
[TBL] [Abstract][Full Text] [Related]
35. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28.
Tanaka K; Kasahara M
Immunol Rev; 1998 Jun; 163():161-76. PubMed ID: 9700509
[TBL] [Abstract][Full Text] [Related]
36. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
[TBL] [Abstract][Full Text] [Related]
37. The components of the proteasome system and their role in MHC class I antigen processing.
Krüger E; Kuckelkorn U; Sijts A; Kloetzel PM
Rev Physiol Biochem Pharmacol; 2003; 148():81-104. PubMed ID: 12687403
[TBL] [Abstract][Full Text] [Related]
38. Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.
Benham AM; Neefjes JJ
J Immunol; 1997 Dec; 159(12):5896-904. PubMed ID: 9550386
[TBL] [Abstract][Full Text] [Related]
39. Hsp90-mediated assembly of the 26 S proteasome is involved in major histocompatibility complex class I antigen processing.
Yamano T; Mizukami S; Murata S; Chiba T; Tanaka K; Udono H
J Biol Chem; 2008 Oct; 283(42):28060-5. PubMed ID: 18703510
[TBL] [Abstract][Full Text] [Related]
40. Proteolytic enzymes involved in MHC class I antigen processing: A guerrilla army that partners with the proteasome.
Lázaro S; Gamarra D; Del Val M
Mol Immunol; 2015 Dec; 68(2 Pt A):72-6. PubMed ID: 26006050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
